The Impact of Prefilled Syringes on Endophthalmitis Following Intravitreal Injection of Ranibizumab-Reference-Cited by-同舟云学术

The Impact of Prefilled Syringes on Endophthalmitis Following Intravitreal Injection of Ranibizumab

Published:2019-03 Issue: Volume:199 Page:200-208
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Storey Philip P.,Tauqeer Zujaja,Yonekawa Yoshihiro,Todorich Bozho,Wolfe Jeremy D.,Shah Sumit P.,Shah Ankoor R.,Koto Takashi,Abbey Ashkan M.,Morizane Yuki,Sharma Priya,Wood Edward H.,Morizane-Hosokawa Mio,Pendri Pooja,Pancholy Maitri,Harkey Shawn,Jeng-Miller Karen W.,Obeid Anthony,Borkar Durga S.,Chen Eric,Williams Patrick,Okada Annabelle A.,Inoue Makoto^ORCID,Shiraga Fumio,Hirakata Akito,Shah Chirag P.,Prenner Jonathan,Garg Sunir^ORCID

Funder

Massachusetts Eye and Ear

Regeneron

Publisher

Elsevier BV

Subject

Ophthalmology

Reference26 articles.

1. Trends in vitreoretinal procedures for medicare beneficiaries, 2000 to 2014;McLaughlin;Ophthalmology,2017

2. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents;Shah;Ophthalmology,2011

3. Eliminating antibiotic prophylaxis for intravitreal injections: a consecutive series of 18,839 injections by a single surgeon;Bhavsar;Retina,2015

4. Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor;Inoue;Ophthalmologica,2011

5. Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes;Lyall;Eye (Lond),2012

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Outcomes and Experiences with Prefilled Syringes Versus Vials for Intravitreal Administration of Anti-VEGF Treatments: A Systematic Review;Ophthalmology and Therapy;2024-07-27

2. Usability of the SB11 Pre-filled Syringe (PFS) in Patients with Retinal Diseases;Advances in Therapy;2024-07-08

3. Risk of post‐injection endophthalmitis peaks within the first three injections of anti‐vascular endothelial growth factor therapy: A nationwide registry‐based study;Acta Ophthalmologica;2024-06-03

4. Risk of Endophthalmitis Based on Cumulative Number of Anti-VEGF Intravitreal Injections;Ophthalmology;2024-06

5. No effect of real-world universal face masking on post-intravitreal injection endophthalmitis rate at a single tertiary academic center;Retina;2024-01-11